News

Company to Convene Expert Symposium in Boston to Discuss Clinical Experiences CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announces that as of late 2012, more than...

Although implantable cardioverter-defibrillators (ICDs) have been used for decades to safeguard patients at risk for experiencing sudden cardiac arrest, their major drawback has been the electrodes (leads), which can break, become infected,...

Heart Metabolics Limited announced that it has closed the first tranche of its Series A financing with secured commitments of US$4 million. The proceeds of the Series A round will be used to advance U.S. clinical development of the company's...

The Anticoagulation Forum (AC Forum) has launched the web-based program, "Anticoagulation Centers of Excellence." The program has been created to help healthcare professionals provide the highest level of care and achieve the best possible...

T32 grant funding trains next generation of leaders in clinical and outcomes research As one of the leading outcomes research centers in the nation, Saint Luke's Mid America Heart Institute has led more than 115 clinical trials in all...

ELIQUIS Demonstrated Superior Risk Reductions Versus Warfarin in Three Key Outcomes — Stroke and Systemic Embolism, Major Bleeding and All-Cause Mortality — for Patients with Nonvalvular Atrial Fibrillation Bristol-Myers Squibb Company and...

Nanostim, Inc., a privately-owned developer of miniaturized, leadless pacemakers, announced the first successful implants of a leadless pacemaker in a series of 11 patients at Homolka Hospital in Prague, Czech Republic. The leadless...

One year after treatment, 80 percent of patients maintain normal sinus rhythm without medication A physician study published in the Polish Journal of Cardiology showed a minimally invasive hybrid ablation procedure known as the Convergent...

Company Begins Evaluation of its Next Generation Pacing Leads The first patient has been implanted with the Boston Scientific Corporation next generation INGEVITY™ pacing leads in a clinical trial designed to establish the safety,...

ECOST Trial Results Published in European Heart Journal BIOTRONIK, a leading manufacturer of innovative medical technology, announced that the European Heart Journal has published the clinical results of the ECOST trial (Effectiveness and...